Shenzhen Chipscreen Biosciences Co (SHSE:688321) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Shenzhen Chipscreen Biosciences Co EBITDA Margin % Related Terms
Shenzhen Chipscreen Biosciences Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen Chipscreen Biosciences Co EBITDA Margin % Chart
SHSE:688321 vs ZTS, UTHR: EBITDA Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Chipscreen Biosciences Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhen Chipscreen Biosciences Co EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shenzhen Chipscreen Biosciences Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Shenzhen Chipscreen Biosciences Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen Chipscreen Biosciences Co (SHSE:688321) has a EBITDA Margin % of 14.47% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shenzhen Chipscreen Biosciences Co and its competitors. This is 11% below median its historical median of 16.34. According to the industry distribution chart, Shenzhen Chipscreen Biosciences Co ranks #463 out of 953 companies in the Drug Manufacturers industry, placing it in the top 48.6%.
Is Shenzhen Chipscreen Biosciences Co's EBITDA Margin % too high?
Shenzhen Chipscreen Biosciences Co's current EBITDA Margin % of 14.47% is 11% below median its 10-year median of 16.34. The Drug Manufacturers industry median EBITDA Margin % is 12.54. Shenzhen Chipscreen Biosciences Co's value of 14.47% is 15.4% above this industry median. Based on the distribution chart, Shenzhen Chipscreen Biosciences Co ranks #463 out of 953 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Shenzhen Chipscreen Biosciences Co has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Chipscreen Biosciences Co's EBITDA Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Shenzhen Chipscreen Biosciences Co ranks #463 out of 953 companies for EBITDA Margin %. This puts Shenzhen Chipscreen Biosciences Co in the upper half of its industry. The industry median EBITDA Margin % is 12.54. Shenzhen Chipscreen Biosciences Co's value of 14.47% is 15.4% above this benchmark. While the company's 10-year median is 16.34 vs. the industry median of 12.54, Shenzhen Chipscreen Biosciences Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.54, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenzhen Chipscreen Biosciences Co's current EBITDA Margin % of 14.47% is 15.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shenzhen Chipscreen Biosciences Co and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen Chipscreen Biosciences Co's current EBITDA Margin % is 14.47%, which is 11% below median its own 10-year median of 16.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Chipscreen Biosciences Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen Chipscreen Biosciences Co (SHSE:688321) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥37.66, compared to a current price of ¥28.46 — trading 24.4% below its estimated fair value. The current EBITDA Margin % is 14.47%, which is 11% below median its 10-year median of 16.34 and 15.4% above the Drug Manufacturers industry median of 12.54. Shenzhen Chipscreen Biosciences Co's overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Shenzhen Chipscreen Biosciences Co (SHSE:688321), the current EBITDA Margin % is 14.47% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shenzhen Chipscreen Biosciences Co (SHSE:688321) Overvalued in 2026?
Based on GuruFocus' analysis, Shenzhen Chipscreen Biosciences Co stock appears to be undervalued.
The current stock price of ¥28.46 is trading 24.4% below its estimated GF Value™ of ¥37.66.
GuruFocus considers Shenzhen Chipscreen Biosciences Co to be Modestly Undervalued.
Key valuation signals for SHSE:688321:
EBITDA Margin %: 14.47% (11% below median its 10-year median of 16.34)
GF Value™: ¥37.66 vs. price of ¥28.46 (24.4% below fair value)
Industry Position: 15.4% above the Drug Manufacturers median (#463 of 953)
No single metric tells the full story. See the SHSE:688321 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shenzhen Chipscreen Biosciences Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688321 has been successfully added to your 
